IHS Chemical Week

World News and Views :: Projects

Carbogen Amcis to Open High Potency API Unit in India

12:29 PM MDT | April 18, 2008 | Deepti Ramesh

Research and active pharma ingredient (API) manufacturer Carbogen Amcis AG (Bubendorf, Switzerland) says that its Indian subsidiary Carbogen Amcis India Ltd. (Ahmedabad, India) will open a facility for high potency APIs at Bavla, India by the first quarter of 2009. The Bavla facility, which is at the site of parent firm Dishman Pharmaceuticals & Chemicals Ltd., will cater to both cytotoxic and non-cytotoxic highly active substances in dedicated areas. Construction is under way, says Carbogen Amcis, which is designing the facility and plans to operate it...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa